![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Roche’s Cobas Liat Test for COVID-19 Granted FDA Emergency Use Authorization
Roche’s Cobas Liat Test for COVID-19 Granted FDA Emergency Use Authorization
The FDA has granted Emergency Use Authorization to Roche’s cobas SARS-CoV-2 nucleic acid test for use on the company’s cobas Liat system.
The point-of-care reverse transcriptase polymerase chain reaction (RT-PCR) test system, which can identify COVID-19 infections in 20 minutes or less during a patient’s visit, offers an alternative to sending test samples to a PCR test laboratory.
Roche says the PCR test will be available for use on the cobas Liat system in July.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct